Literature DB >> 25925714

A novel protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery under cardiopulmonary bypass.

Mizuho Odaka1, Kenji Minakata, Hideaki Toyokuni, Kazuhiro Yamazaki, Atsushi Yonezawa, Ryuzo Sakata, Kazuo Matsubara.   

Abstract

OBJECTIVE: This study aimed to develop and assess the effectiveness of a protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery.
METHODS: We established a protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery. This novel protocol was assessed by comparing patients undergoing open heart surgery before (control group; n = 30) and after its implementation (protocol group; n = 31) at Kyoto University Hospital between July 2012 and January 2013.
RESULTS: Surgical site infections (SSIs) were observed in 4 control group patients (13.3 %), whereas no SSIs were observed in the protocol group patients (P < 0.05). The total duration of antibiotic use decreased significantly from 80.7 ± 17.6 h (mean ± SD) in the control group to 55.5 ± 14.9 h in the protocol group (P < 0.05). Similarly, introduction of the protocol significantly decreased the total antibiotic dose used in the perioperative period (P < 0.05). Furthermore, antibiotic regimens were changed under suspicion of infection in 5 of 30 control group patients, whereas none of the protocol group patients required this additional change in the antibiotic regimen (P < 0.05).
CONCLUSION: Our novel antibiotic prophylaxis protocol based on preoperative kidney function effectively prevents SSIs in patients undergoing open heart surgery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25925714     DOI: 10.1007/s11748-015-0552-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  18 in total

Review 1.  ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  1999-09-15       Impact factor: 2.637

Review 2.  The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass.

Authors:  B Mets
Journal:  Acta Anaesthesiol Scand       Date:  2000-03       Impact factor: 2.105

3.  Coagulase-negative staphylococci and sternal infections after cardiac operation.

Authors:  A Tegnell; C Arén; L Ohman
Journal:  Ann Thorac Surg       Date:  2000-04       Impact factor: 4.330

4.  Antibiotic prophylaxis for coronary bypass grafting. Comparison of a five-day and a two-day course.

Authors:  D J Hillis; F L Rosenfeldt; W J Spicer; G R Stirling
Journal:  J Thorac Cardiovasc Surg       Date:  1983-08       Impact factor: 5.209

Review 5.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

6.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.

Authors:  A J Mangram; T C Horan; M L Pearson; L C Silver; W R Jarvis
Journal:  Am J Infect Control       Date:  1999-04       Impact factor: 2.918

7.  Perioperative antimicrobial prophylaxis in cardiovascular surgery. A prospective randomized trial comparing two day cefuroxime prophylaxis with four day cefazolin prophylaxis.

Authors:  S Geroulanos; S Oxelbark; M Turina
Journal:  J Cardiovasc Surg (Torino)       Date:  1986 May-Jun       Impact factor: 1.888

8.  Effect of cardiopulmonary bypass on cefazolin disposition.

Authors:  K W Miller; H G McCoy; K K Chan; R P Fischer; W G Lindsay; R D Seifert; D E Zaske
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

9.  Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis.

Authors:  Maureen K Bolon; Monica Morlote; Stephen G Weber; Bruce Koplan; Yehuda Carmeli; Sharon B Wright
Journal:  Clin Infect Dis       Date:  2004-04-21       Impact factor: 9.079

10.  Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain.

Authors:  M C Fariñas; F Gald Peralta; J M Bernal; J M Rabasa; J M Revuelta; J González-Macías
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.